Hjem › Aterosklerose › Alabama
Aterosklerose kliniske forsøg i Alabama
8 studier for Aterosklerose søger deltagere på steder i Alabama.
Byer i Alabama
Officiel studietekst (engelsk)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Heart Center Research, LLC, Huntsville
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Birmingham Clinical Research, Birmingham
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Alliance For Multispecialty Research - Daphne, Daphne
- Eastern Shore Research Institute, Fairhope
- Heart Center Research LLC, Huntsville
- og 2 flere
RekruttererFase 3
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Heart Center Research, LLC, Huntsville
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology of North Alabama, Decatur
- Nephrology Consultants, LLC, Huntsville
- DaVita Clinical Research Montgomery, Montgomery
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Athens
- Research Site, Birmingham
- Research Site, Birmingham
- og 8 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT07000357Pelacarsen Roll-over Extension Program
- Parkway Medical Center, Birmingham
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 29. jul. 2026 · NCT06875973Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure
- University of Alabama at Birmingham, Birmingham
Rekrutterer
Alder 18 til 55 · Alle køn · Opdateret 3. sep. 2025 · NCT06962488Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.